All In MedTech

Device Trial Radar · NCT03706534

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

Breast Ultrasound Image Reviewed With Assistance of Deep Learning

Last checked: Nov 20, 2026Latest source record: Oct 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

300

Actual

Start

Sep 20, 2018

Primary completion

Nov 30, 2019

Study completion Jan 31, 2020

Sponsor

Lead sponsor
Samsung MedisonNot on our public-company list
Sponsor type
Industry
Collaborators
University of Rochester
First posted
Oct 16, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Device feasibility
FDA-regulated device
No
Who can join
All sexes, from 19 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study evaluates a second review of ultrasound images of breast lesions using an interactive "deep learning" (or artificial intelligence) program developed by Samsung Medical Imaging, to see if this artificial intelligence will help the Radiologist make more accurate diagnoses.

Conditions

  • Breast Cancer
  • Breast Lesions
  • Breast Mass

Interventions

  • Ultrasound Image review with CADeDevice

    This software is a computer-aided detection (CADe) software application, designed to assist radiologist to analyze breast ultrasound images. S-Detect automatically segments and classifies shape, orientation, margin, lesion boundary, echo pattern, and posterior feature characteristics of user-selected region of interest. The device uses deep learning methods to perform tissue segmentation and classification of images.

  • Ultrasound Image review with CADxDevice

    This software is also a computer-assisted diagnostic(CADx) software application, designed to assist a medical doctor in determining diagnosis by presenting whether a lesion is malignant in a breast ultrasound image obtained from an ultrasound imaging device.

  • Ultrasound Image manual reviewDevice

    The images will be reviewed by the radiologists using BIRADS scheme without any assistance of artificial assistance. This review will be done off-line using a separate program in entirely manual mode. During this review, BIRADS descriptor choices by each radiologist and the time it takes for the radiologist to make such decision will be stored.

  • BiopsyProcedure

    Suspicious lesions found on breast ultrasound are then followed either by ultrasound guided biopsy or ultrasound imaging every 6 months for two years. For those who undergo biopsy, ultrasound provides images which are used to localize the lesion and guide the placement of the biopsy needle. The sample is sent to pathology for diagnosis, while the ultrasound guidance images are stored. For those who have imaging follow-up, ultrasound images of the breast mass are obtained, digitally stored and interpreted by the radiologist typically using BIRADS scheme.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Concordance rateTime frame: 2 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Rochester

    Rochester, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.